Abiopharma

New Form 144 - Arcutis Biotherapeutics, Inc. Filed: 2025-08-08 AccNo: 0002007317-25-000828 Size: 6 KB

New Form 3 - GERON CORP Filed: 2025-08-08 AccNo: 0000886744-25-000060 Size: 388 KB

New Form 144 - IRONWOOD PHARMACEUTICALS INC Filed: 2025-08-08 AccNo: 0002053936-25-000005 Size: 4 KB

New Form 4 - AMEDISYS INC Filed: 2025-08-08 AccNo: 0000896262-25-000067 Size: 5 KB

New Form 8-K/A - Vireo Growth Inc. Filed: 2025-08-08 AccNo: 0001558370-25-010924 Size: 2 MB Item 9.01: Financial Statements and Exhibits

New Form 144 - IRONWOOD PHARMACEUTICALS INC Filed: 2025-08-08 AccNo: 0002061679-25-000004 Size: 5 KB

New Form SCHEDULE 13G/A - Chemours Co Filed: 2025-08-08 AccNo: 0001104659-25-075694 Size: 15 KB

New Form 144 - ARTIVION, INC. Filed: 2025-08-08 AccNo: 0001950047-25-005542 Size: 4 KB

New Form 10-Q - Alpha Teknova, Inc. Filed: 2025-08-08 AccNo: 0000950170-25-105825 Size: 9 MB

New Form 425 - Carisma Therapeutics Inc. Filed: 2025-08-08 AccNo: 0001104659-25-075689 Size: 30 KB

New Form 4 - Turnstone Biologics Corp. Filed: 2025-08-08 AccNo: 0001415889-25-021338 Size: 14 KB

New Form 144 - Doximity, Inc. Filed: 2025-08-08 AccNo: 0001950047-25-005540 Size: 6 KB

New Form 4 - CRISPR Therapeutics AG Filed: 2025-08-08 AccNo: 0001688192-25-000004 Size: 5 KB

Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update

New Form 4 - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-08-08 AccNo: 0001104659-25-075687 Size: 8 KB